Abstract. Peptide sequences from a proteome can be partitioned into N mutually exclusive sets and used to identify their parent proteins in a sequence database. This is illustrated with the human proteome (http://www.uniprot.org; id UP000005640), which is partitioned into eight subsets KZ If the full peptide sequence is known then over 98% of the proteins in the proteome can be identified from such sequences. The rate exceeds 78% if the positions of four internal residue types are known. When the standard set of 20 amino acids is replaced with an alphabet of size four based on residue volume the identification rate exceeds 96%. In an information-theoretic sense this last result suggests that protein sequences effectively carry nearly the same amount of information as the exon sequences in the genome that code for them using an alphabet of size four. An appendix discusses possible in vitro methods to create peptide partitions and potential ways to sequence partitioned peptides.
Introduction
Partitioning of peptides into mutually exclusive subsets of sequences with known properties can make protein sequencing and/or identification based on database search easier. If a full or partial sequence from a subset is known identification of the parent protein is more efficient because the search space is considerably smaller. Here it is shown by computation that a partition with N = 8 sets can lead to protein identification rates in excess of 90%. An appendix discusses practical methods for in vitro cleaving of proteins, physical separation of cleaved peptides into subsets, and full or partial sequencing of partitioned peptides.
Peptide partitions and their properties
Consider peptide sequences in a proteome that have the form X1Z * X2, where X1 and X2 are drawn from a small number of residue types, Z is one of the remaining residue types, and Z * ≡ 0 or more occurrences of Z. Table 1 shows three such partitions for different X1 and X2 at some pH value. The following are some properties of such partitions; they are derived in part from computations performed on the complete sequence database of the human proteome (20207 sequences). 1) Partitioning makes protein identification based on comparison of peptide sequences with sequences in a proteome database simpler because it reduces the search space considerably. This can be seen in Table 2 , which shows the number of peptides in each subset of an 8-set partition and the computed number of protein-identifying peptides in it; the average reduction of the search space is around 8. Also, on computing the set union operation (U) over the identifying peptides in different subsets the percentage of identifiable proteins in a proteome increases appreciably. an element can be a protein identifier and at the same time be a subsequence of a peptide in any of the other seven subsets. This is because it only needs to be a unique identifier for a protein containing an element of Z * ; being in the distinct subset Z * it carries context information that is hidden. Thus in the protein sequence that it identifies it is not preceded by K in any sequence in the proteome, it is either followed by K or is the last peptide at the end of the protein sequence, and it is not followed by R, D, or E. 2) With partitioned peptides, sequencing of peptides in one subset is not affected by peptides in another because they occur in two distinct and physically separate sequencing procedures. 
A partition based on a reduced amino acid alphabet
Amino acids vary in volume [1] but in most cases the differences are small. In [2] they are coarsely partitioned into four subsets labeled Minuscule, Small, Intermediate, and Large. These subsets are encoded here with the reduced alphabet {B, U, X, Z}. (This alphabet, which is not part of the 1-letter standard amino acid code, was chosen to make the database search algorithms simpler.) The mapping is as follows: {G,A,S,C} → B, {T,D,P,N,V} → U, {E,Q,L,I,H,M,K} → X, {R,F,Y,W} → Z. The sequences in the proteome database are recoded with this reduced alphabet and protein identifying peptides are obtained by searching for them in the sequence database. By redefining the subsets three more volume-based partitions with 5 or 6 subsets are possible: (Further post-processing using HMM or similar learning-based algorithms [3] [4] [5] [6] can result in further improvements in identification, but such a development is outside the scope of the present report.)
These results show that almost all (> 96%) proteins in the proteome can be identified when they are coded with a reduced four-character alphabet. This suggests that at the identification level protein sequences contain, in an information-theoretic sense, about the same amount of information as the exons in the genome that code for them. Whether this is biologically significant or is a computational artifact remains to be seen.
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Frequency distribution of residues in the human proteome A-1 Peptide partitioning in vitro Partitioning of peptides can be done in vitro in two steps: cleaving and separation. High-specificity peptidases or chemical agents are available to cleave before or after a specific residue [7, 8] , where 'before' or 'after' means cleavage on the N-terminal or Cterminal side of the residue. (Peptide sequences are usually listed from N-terminal to C-terminal.) Some of these peptidases/agents are listed in Table A-1 below. Peptides can be separated using a variety of methods based on the electric charge they carry. (This charge can be calculated using the Henderson-Hasselbach equation [9] .) Examples of separation methods [10] include isoelectric focusing (IEF), paper chromatography (PC), and ion-exchange chromatography (IEC). In
Step 1 proteins in the assay sample are broken into peptides using multiple peptidases or chemical agents in sequence [11] . This enables breaking a protein into peptides with desired start and end residues (see Table 1 in the main text). For example LysN creates peptides starting with K, while formic acid creates peptides ending in D. When these two are applied in sequence (in any order), the result is peptides that start with K and end with D. With four peptidases/chemical agents, there are 24 different orders of application. The optimum order may be determined experimentally.
In
Step 2 the peptides created in Step 1 are inserted into an electrolyte with a known pH value and separated into subsets based on the charge they carry at that pH value. IEF uses an electrolyte with a pH gradient and an electrical field that moves a peptide to a point along the gradient where its effective charge is zero. This point is the peptide's 'isoelectric focus' or pI value. IEF has a pI resolution of 0.001. , KZ * , Z * R, and KZ * R, followed by IEF. This leads to an 8-subset partition in which the maximum peptide frequency in each subset is separated from that in another by a pI value of at least 0.1. For the human proteome the distribution of peptide frequency vs pI for each of the 8 subsets of the partition is shown in Figure A Peptides can be further separated by mass or size using 2-D gel electrophoresis (GE) [12] . In practice each step before sequencing in Figure A -1 requires an extraction step involving elution, filtration, etc., in which the target (peptide fragments) is extracted and input to the next step. With the 8-subset partition example considered above five extraction steps are required, one after each cleavage step and one after IEF. This means that even if each extraction is 90% efficient, less than 60% of the sample will enter the sequencing stage.
A-2 Peptide sequencing in practice
Two practical methods to sequence peptides in partitioned subsets are considered here. They are mass spectrometry (MS) [13] , which sequences peptides in the bulk, and nanopore sequencing, which is a single molecule method [14, 15] .
In MS, peptides are extracted from the gel after GE and split into ionized fragments before entering the spectrometer, which then outputs a mass spectrum for a peptide. A variety of algorithms are available to predict a partial or full sequence from the spectrum by comparison with MS spectra databases and identify the container protein [16, 17] . With partitioned peptides, the task is simplified because a peptide belongs to a restricted subset.
In conventional nanopore sequencing of polymers (DNA, RNA, protein) the analyte translocates through the pore by a combination of diffusion and electrophoresis in the presence of an electric field. Discrimination among monomers (bases in DNA and RNA; residues in peptides) is based on the ability to detect measurable differences in the current blockade due to different monomers. Protein sequencing is more difficult than DNA sequencing because of the need to discriminate among 20 residue types against 4 base types. This is further complicated by homopolymers because successive blockade levels have the same value. One way to resolve this is to use a pore in an atom-thin membrane of graphene or MoS2. The analyte translocation distance through the pore is then less than the distance between two successive monomers so blockade transitions between two monomers can be better distinguished.
Sequencing that is based on pore current blockades has to contend with ever present noise, so a high signal to noise ratio (SNR) is required. One way to increase SNR is to increase the transmembrane potential and thereby increase pore current levels; however it cannot exceed a few 100s of millivolts. Additionally the analyte takes less than 100 ns to pass through the pore, which puts detection beyond the capacity of available detectors. Even with available detector bandwidths, higher bandwidth means higher noise levels. Several methods of slowing down the analyte have been proposed [18] , most of them fall short. Two potential exceptions to this are: 1) slowdown based on the use of a hydraulic pressure gradient that is opposed to the transmembrane potential [19] ; and 2) use of a high viscosity electrolyte (= RTIL or room temperature ionic liquid) [20] in the cis chamber, which has been found to decrease translocation speeds by a factor of ~200 in DNA sequencing with a pore in an atom-thin MoS2 membrane.
In [2] peptide sequencing is based on using a reduced amino acid alphabet with four characters and mapping current blockades caused by residues to it. Post-processing of signal data with four measurable levels of discrimination uses a hidden Markov model (HMM) to construct the reverse map from reduced alphabet to full alphabet and the peptide sequence therefrom. If the notion of a reduced alphabet is combined with that of peptide partitions, nanopore sequencing can in principle identify more than 96% of the proteins in the human proteome (see Table 3 in the main text).
The dependence on pore currents to detect monomers can be avoided if selected residue types in a peptide are labeled with fluorescent tags and detected optically using Total Internal Reflection Fluoroscopy (TIRF) [21, 22] . This results in a partial sequence for a peptide, which can be used to identify the parent protein through database search. (Pore current blockades, while still present, are not used for monomer detection.) Figure A-4 shows a schematic. Peptide translocation through the pore is controlled by a combination of transmembrane potential and hydraulic gradient, as in [19] , and/or by using an RTIL, as in [20] . As the peptide threads through the pore into trans an emerging residue that is tagged fluoresces in the presence of a laser input and is identified by a photosensor. With additional signal processing positional information for the tagged residues in the peptide sequence is obtained.
TIRF has a resolution in the submillisecond range, which appears achievable with the above setup. It can distinguish up to 13 intensity levels so peptides can contain up to 13 tagged residues of the same type. It has the further advantage of being able to sense homopolymers correctly because every residue in the homopolymer is detected by a quantum jump in the photo-intensity, unlike with electrical sensing in which pore current measurements yield blockade current levels that are the same for successive identical residues. Consider for example sequencing peptides in KZ*R, KZ*D, and KZ*E. Residues K, R, E, and D can be coded using two tags, denoted TERM-1 and TERM-2 (K and R; K and E; K and D). A small number k of internal residue types from the set Z can also be tagged. With k = 2 let the latter be INTL-3 and INTL-4. A tagged residue causes a step increase in the intensity of the measured signal TERM-m(t) or INTL-n(t) from the nanopore for tag type m or n. The residue order can then be constructed from the individual signals TERM-1(t), INTL-3(t), INTL-4(t), and TERM-2(t). Position information can be estimated from time differences between successive tag detection times obtained from the signals TERM-m(t) and INTL-n(t) using deconvolution algorithms similar to those used in DNA sequencing [3] [4] [5] [6] . From the resulting partial sequence the full peptide sequence can be identified by database search. If it is also a unique identifier for its container protein the latter can be identified as well. Figure 1 in the main text shows calculated frequency distributions of identifying peptides in KZ*R, KZ*D, and KZ*E with two or four internal tag types. With KZ*R, KZ*D, and KZ*E, the boundary between two peptides that pass through the pore in succession is known from the labels of the first and last residues. Whether the peptides enter C-terminal or N-terminal first, their end labels always occur in pairs (for example, with labeled internal residues X and Z: K.X.Z..R, K.Z...Z.....R, RXX..Z...K, etc.). With KZ*, Z*R, Z*D, and Z*E, only one starting/terminal residue is fixed. With a total of four tag types, the signals for KZ* would be TERM-1(t), INTL-2(t), INTL-3(t), and INTL-4(t). With Z* there is neither a starting nor an ending label, so the first signal is replaced by INTL-1(t). Two successive peptides S1 and S2 are detected as follows: S1 = K.X.Z.. , S2 = K.X.X.. → detected as S12 = K.X.Z.....K.X.X (1a) S1 = K.X.Z.., S2 = ..X..K → detected as S12 = K.X.Z. ...X..K (1b) S1 = ..X..Z.B.., S2 =..Z..X.. → detected as S12 = ..X..Z.B....Z..X..
In each case the boundary between the two peptides can be discerned by searching for partial sequences S1' and S2' such that S1''..S2'' = the observed S12, where S1'' (or S2'') = S1' (or S2') or its reverse. As an example Table A-2 shows the computed number of identifiable proteins from peptides with a total of four tag types whose partial sequences are truncated to the first tagged residue at one or both ends before search. Nanopore-based peptide sequencing can also be used to quantify proteins in an assay sample. Consider a mixture of proteins {(Ni, Pi, Ii): i = 1, 2, ...} where Ni is the number of molecules of the i-th protein in the mixture, Pi the number of peptides per molecule of the protein (= the number of peptides created from a single molecule by the cleaving steps in Figure 1 , main text), and Ii (0 ≤ Ii ≤ Pi) the number of identifying peptides per molecule (this is known by precomputation; see Table 2 , main text). Let Ntotal be the total number of peptides sensed and Ii-identified the number of identified peptides in protein i. If peptide entry into a cell is totally random, then after a sufficiently long run Ni can be estimated as Ñi = Ii-identified /Ii, the corresponding fraction is Gi = Ñi /Ntotal. The number of peptides that do not yield identifying information is Nnon-identifying = Ntotal -∑Ii-identified, where the summation is over all the identified proteins. This number includes peptides that are found in more than one protein as well as impurities in the input sample.
A-3
Frequency distribution of residues in the human proteome The 20 residue types occur with different frequencies in the human proteome. Frequency distribution of residues in the human proteome (Uniprot id UP000005640) (Z/X/U/B represents 838 ambiguously labeled residues in the sequence database.)
